Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 and ED90 of ropivacaine for caudal block in children with hypospadias
ChiCTR2200057902Phase 4Recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Mar 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of ropivacaine in hypospadias, sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: 50% minimum effective volume (ED50 by volume), 90% minimum effective volume (ED90 by volume) and 4 more. Started Mar 2022; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
hypospadias
Beyond the preview
Go deeper on ChiCTR2200057902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057902.